Skip to Main Content

Paper Details

Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer.
Int J Cancer
4
2021
Author NameAffiliation
William B HillegassUniversity of Mississippi Medical Center
  • 1 - 1

Datasets

Release 1.2